Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Capecitabine discount card?
Methscopolamine cost?
Deferasirox 500 mg price?
Capecitabine category?
Avatrombopag brand name?

Rybrevant 2023 sales janssen amivantamab 2023 revenue?

See the DrugPatentWatch profile for Rybrevant

How much did Rybrevant (amivantamab) sell in 2023?

Janssen’s Rybrevant (amivantamab-vmjw) generated 2023 sales of $4.1 billion. [1]

What was the 2023 revenue number for amivantamab (Rybrevant)?

Rybrevant’s 2023 revenue figure (reported as sales) was $4.1 billion. [1]

Where do these figures come from?

These 2023 sales/revenue figures are compiled from DrugPatentWatch.com’s drug sales tracking. [1]

Source

  1. https://www.drugpatentwatch.com/patent/rybrevant-amivantamab-vmjw/


Other Questions About Rybrevant :

How does rybrevant treat lung cancer? Is rybrevant an iv infusion? What is the risk of infusion reactions with rybrevant? Can rybrevant be used for exon 20 insertions?